Latest Breaking News On - Clinician brief summary instructions - Page 1 : comparemela.com

Pear Therapeutics, Inc.: Pear Therapeutics Presents Real-World Data Showing Reduction in Healthcare Resource Utilization and Associated Costs in Adults Using Somryst at ISPOR Europe

Somryst is the only FDA-authorized prescription digital therapeutic (PDT) for the treatment of chronic insomnia Analysis demonstrated potential per-patient cost reductions over 24 months of

United statesMeara murphyYuri maricichPabout somrystHealth care providerEmergency departmentSoftware precertification pilot programAmerican college of physiciansAmerican academy of sleep medicinePear therapeutics us incCorporate communicationsPear therapeutics incChief medical officerAmerican academySleep medicineAmerican college

Pear Therapeutics and Cove Behavioral Health to Provide Patients Access to Prescription Digital Therapeutic for the Treatment of Opioid Use Disorder

Press release content from Business Wire. The AP news staff was not involved in its creation.

United statesTampa bayMeara murphyLinda mckinnonCatherine munchDeanna obregonJulia strandbergHuman service substance abuseCove behavioral healthTampa bay communityUs department of healthMental health services administrationSoftware precertification pilot programDepartment of childrenPear therapeutics us incCentral florida behavioral health network

Pear Therapeutics (PEAR) Announces New 12-Month Analysis Showing Reduction in Healthcare Resource Utilization and Associated Costs in Patients Treated with reSET-O

Pear Therapeutics (PEAR) Announces New 12-Month Analysis Showing Reduction in Healthcare Resource Utilization and Associated Costs in Patients Treated with reSET-O
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Yuri maricichHead of development at pear therapeuticsPear therapeutics incChief medical officerOpioid use disorderSafety informationPress releaseClinician brief summary instructions

Pear Therapeutics (PEAR) Presents Interim Real-World Data Showing Significant Reductions in Symptoms of Chronic Insomnia, Anxiety and Depression with Somryst

Pear Therapeutics (PEAR) Presents Interim Real-World Data Showing Significant Reductions in Symptoms of Chronic Insomnia, Anxiety and Depression with Somryst
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

North carolinaUnited statesYuri maricichAmerican college of physiciansHealth care providerAmerican academy of sleep medicinePatient health questionnairePear therapeutics incHead of developmentAnnual meetingAssociated professional sleep societiesChief medical officerGeneralized anxiety disorderSeverity indexPabout somrystAmerican academy

Pear Therapeutics Joins Epic App Orchard To Enable Clinicians To Monitor Prescription Digital Therapeutics

Pear Therapeutics, Inc., the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs),.

Julia strandbergEpic systems corporationPear therapeutics us incPear therapeutics incSoftware precertification pilot programEpic app orchardKapp orchardChief commercial officerCurrent procedural terminologyRemote therapeutic monitoringPear therapeuticsPrecertification pilotSafety informationPress releaseClinician brief summaryOpioid use disorder